ALC Stock Recent News

At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.

Here is how Alcon (ALC) and Molina (MOH) have performed compared to their sector so far this year.

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.

Alcon's (ALC) Surgical business continues to gain from diverse portfolio and incremental innovation.

Alcon's (ALC) Vivity Registry study data highlights the lens's versatility in treating a wide range of patients.

Here is how Alcon (ALC) and RxSight, Inc. (RXST) have performed compared to their sector so far this year.

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Quarterly results from large retailers will highlight this week's earnings lineup but there are a few healthcare companies that investors will want to pay attention to as well.

Alcon stock is currently trading at over 30x earnings, which is considered high for a company not expected to deliver EPS above 20 - 25% in the next few years. Despite the high trading multiple, Alcon has a strong business model and is a leader in the eye care industry, with recent positive developments in its product line and services. Alcon's share price is currently inflated due to hopes of significant free cash flow being diverted to shareholders, but I suggest this optimism may be misplaced and recommend a hold rating for the company.

In Equipment, Alcon (ALC) continues to upgrade and expand its installed base with the CENTURION and LEGION devices.